749 related articles for article (PubMed ID: 12428567)
21. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
22. [Usefulness of the genetic study in the diagnosis of medullary carcinoma of the thyroid].
Rafecas A; Ribas Y; Villabona C; Viladrich M; Figueras J; Fabregat J; Torras J; Gómez JM; Jaurrieta E
Med Clin (Barc); 1998 Nov; 111(16):619-22. PubMed ID: 9881336
[TBL] [Abstract][Full Text] [Related]
23. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement.
Bugalho MJ; Santos JR; Sobrinho L
J Surg Oncol; 2005 Jul; 91(1):56-60. PubMed ID: 15999359
[TBL] [Abstract][Full Text] [Related]
24. Radioactive iodine treatment in medullary thyroid carcinoma.
Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
[TBL] [Abstract][Full Text] [Related]
25. Medullary thyroid carcinoma presenting with an initial CEA elevation.
Abraham D; Delbridge L; Clifton-Bligh R; Clifton-Bligh P; Grodski S; Robinson BG; Messina M; Sidhu S
ANZ J Surg; 2010 Nov; 80(11):831-3. PubMed ID: 20969693
[TBL] [Abstract][Full Text] [Related]
26. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
[TBL] [Abstract][Full Text] [Related]
27. [Medullary carcinoma of the thyroid: diagnosis and therapy].
Giuffrida D; Ferraù F; Bordonaro R; Mattina M; Priolo D; Aiello RA; Cordio S; Motta S; Failla G
Clin Ter; 2000; 151(1):29-35. PubMed ID: 10822879
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma.
Allen SM; Bodenner D; Suen JY; Richter GT
Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888
[TBL] [Abstract][Full Text] [Related]
29. [Detection of remnants after removal of medullary thyroid carcinoma].
Zhang J; Dai W; Lian X; Meng X; Hu Y; Bai Y; Li F; Zhang B
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):19-21. PubMed ID: 11831978
[TBL] [Abstract][Full Text] [Related]
30. Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.
Cupisti K; Wolf A; Raffel A; Schott M; Miersch D; Yang Q; Eisenberger CF; Röher HD; Knoefel WT
Ann Surg; 2007 Nov; 246(5):815-21. PubMed ID: 17968174
[TBL] [Abstract][Full Text] [Related]
31. [Familial thyroid medullary carcinoma without associated neoplasms].
Lisa Catón V; Peña Somovilla JL; Ochoa Gómez FJ; Salcedo Aguilar FJ; Vilella Morato A; Campo Hernández JM
An Med Interna; 1994 Sep; 11(9):452-4. PubMed ID: 7858091
[TBL] [Abstract][Full Text] [Related]
32. [Medullary thyroid carcinoma--familial or sporadic disease?].
Høie J; Jørgensen OG; Nesland JM; Møller P; Bjøro K
Tidsskr Nor Laegeforen; 1994 Oct; 114(25):2951-4. PubMed ID: 7974404
[TBL] [Abstract][Full Text] [Related]
33. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
[TBL] [Abstract][Full Text] [Related]
34. Hereditary medullary thyroid carcinoma.
Vasen HF; Vermey A
Cancer Detect Prev; 1995; 19(2):143-50. PubMed ID: 7750101
[TBL] [Abstract][Full Text] [Related]
35. Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis.
Meijer JA; le Cessie S; van den Hout WB; Kievit J; Schoones JW; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2010 Apr; 72(4):534-42. PubMed ID: 19563448
[TBL] [Abstract][Full Text] [Related]
36. Long-term prognosis of medullary thyroid carcinoma.
Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
[TBL] [Abstract][Full Text] [Related]
37. Surgical management of sporadic medullary thyroid cancer.
Noullet S; Trésallet C; Godiris-Petit G; Hoang C; Leenhardt L; Menegaux F
J Visc Surg; 2011 Sep; 148(4):e244-9. PubMed ID: 21885365
[TBL] [Abstract][Full Text] [Related]
38. Spurious hypercalcitoninemia in patients with nodular thyroid disease induced by heterophilic antibodies.
Kim JM; Chung KW; Kim SW; Choi SH; Min HS; Kim JN; Won WJ; Kim SK; Lee JI; Chung JH; Kim SW
Head Neck; 2010 Jan; 32(1):68-75. PubMed ID: 19536770
[TBL] [Abstract][Full Text] [Related]
39. [Thyroid carcinoma].
Tamaki H
Gan To Kagaku Ryoho; 2005 Apr; 32(4):561-5. PubMed ID: 15853229
[TBL] [Abstract][Full Text] [Related]
40. Benefit of measuring basal serum calcitonin to detect medullary thyroid carcinoma in a Danish population with a high prevalence of thyroid nodules.
Hasselgren M; Hegedüs L; Godballe C; Bonnema SJ
Head Neck; 2010 May; 32(5):612-8. PubMed ID: 19691107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]